Effects of vitamin D supplementation along with endurance physical activity on lipid profile in metabolic syndrome patients: A randomized controlled trial.

What Was Tested

Researchers studied Vitamin D, K2, Magnesium and Zinc in this randomized controlled trial publication.

This study was conducted to determine the effects of vitamin D supplementation along with endurance physical activity on lipid profile among metabolic syndrome patients.

Who Took Part

The abstract describes 70 patients taking part.

PubMed indexes the participants as adults and middle-aged adults, both men and women.

In a parallel randomized placebo controlled trial, 70 metabolic syndrome patients, were randomly assigned into three groups.

How the Study Was Run

The design is described as randomized, placebo-controlled and parallel-group.

Random assignment meant chance, not the researchers, decided who got Vitamin D, K2, Magnesium and Zinc and who got the comparison, which limits bias.

The comparison arm used a placebo, so changes seen with Vitamin D, K2, Magnesium and Zinc could be set against what happens without it.

Groups ran in parallel: each of the patients stayed in one arm throughout.

Statistical analysis was performed using SPSS version 20.

What Was Measured

The subject headings attached to it are Biomarkers, Dietary Supplements, Exercise, Lipids, Metabolic Syndrome, Prognosis and Vitamin D.

The authors tagged it with the keywords Iraq, Lipid profile and Physical activity.

What This Means in Plain Language

The paper is a randomized, placebo-controlled and parallel-group study of Vitamin D, K2, Magnesium and Zinc in 70 patients.

Results are reported in around 6 sentences of the abstract; we leave them to the paper itself rather than summarise them.

The publication is from 2019 (Diabetes & metabolic syndrome), a journal based in Netherlands.

More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.